KCAS Webinar (Dec 18th) – Applying the Appropriate Technologies to Address the Bioanalytic Complexities of Antibody-Drug Conjugates
As the field of oncology has evolved, the toxicity of therapeutic agents has driven the development of drugs that target and kill tumors compared to more general therapies that can also impact healthy cells. Principal amongst these therapies is the use of …